TY  - JOUR

T1  - Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US

JO  - Cost Effectiveness and Resource Allocation

PY  - 2020/01/01

AU  - Thokala P

AU  - Stevenson M

AU  - Kumar VM

AU  - Ren S

AU  - Ellis AG

AU  - Chapman RH

ED  - 

DO  - DOI: 10.1186/s12962-020-00234-8

PB  - Springer Science and Business Media LLC

VL  - 18

IS  - 1

Y2  - 2024/10/18

ER  -